retroperitoneal lymph node dissection (Eppendorf AG)
Eppendorf AG is a verified supplier 
90
Structured Review
Eppendorf AG
retroperitoneal lymph node dissection
Retroperitoneal Lymph Node Dissection, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymph+node+dissection/retroperitoneal+lymph+node+dissection/pm40378498-20-4-74
Average 90 stars, based on 1 article reviews
Retroperitoneal Lymph Node Dissection, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymph+node+dissection/retroperitoneal+lymph+node+dissection/pm40378498-20-4-74
Average 90 stars, based on 1 article reviews
retroperitoneal lymph node dissection - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Article Snippet: Received March 4, 2005, revision received July 22, 2005; accepted August 25, 2005.. BACKGROUND.. The objective of this study was to compare the ability of the 1992 American Joint Committee on Cancer (AJCC) TNM staging system for nonorganconfined prostate carcinoma (PCa) (pathologic T3 [pT3a], pT3b,and pT3c) to predict biochemical recurrence (BCR) after radical prostatectomy with its revision from 1997/2002 (pT3a and pT3b). Article Title: External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection. Article Snippet: Jens Hansen,* Michael Rink, Marco Bianchi, Luis A. Kluth, Zhe Tian, Sascha A. Ahyai, Shahrokh F. Shariat, Alberto Briganti, Thomas Steuber, Margit Fisch, Markus Graefen, Pierre I. Karakiewicz, and Felix K.-H. Chun Martini Clinic, Prostate Cancer CentreatUniversityMedical CentreHamburg-Eppendorf,Hamburg,Germany Cancer PrognosticsandHealthOutcomesUnit,UniversityofMontrealHealthCenter,Montreal,Quebec,Canada DepartmentofUrology,UniversityMedical CentreHamburg-Eppendorf,Hamburg,Germany DepartmentofUrology,Weill CornellMedical College,NewYork Presbyterian-Hospital,NewYork,NewYork DepartmentofUrology,Vita-Salute San RaffaeleUniversity,Milan, Italy Article Title: Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study. Article Snippet: Objective To examine the rates of adherence to guidelines for pelvic lymph node dissection (PLND) in patients treated with radical cystectomy (RC) and to identify predictors of omitting PLND.. Materials and methods We relied on 66,208 patients treated with RC between 2004 and 2013 within the National Inpatients Sample (NIS) database.. We examined the rates of PLND according to year of surgery, patient and hospital characteristics. Dissection:Article Title: Perioperative morbidity of open retroperitoneal lymph node dissection for testicular germ cell tumors: an in-depth single center analysis according to European Association of Urology guidelines of complication reporting and a scoping literature review. Article Snippet: .. Article Title: Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer. Article Snippet: .. A group of 65 patients who underwent radical en Article Title: Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines. Article Snippet: Pelvic lymph node dissection for prostate cancer: Adherence and accuracy of the recent guidelines Firas Abdollah, Al’a Abdo, Maxine Sun, Jan Schmitges, Zhe Tian, Alberto Briganti, Shahrokh F Shariat, Paul Perrotte, Francesco Montorsi and Pierre I Karakiewicz Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montreal Health Centre, Montreal, Quebec, Canada; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; Martini Clinic, Prostate Cancer Center University Hospital Hamburg-Eppendorf, Hamburg, Germany; and Department of Urology, Weill Medical College of Cornell University, New York, New York, USA Article Title: Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection. Article Snippet: Giorgio Gandaglia,* Jonas Schiffmann, Thorsten Schlomm, Nicola Fossati, Marco Moschini, Nazareno Suardi, Felix K. H. Chun, Francesco Montorsi, Markus Graefen, and Alberto Briganti Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy Martini-Clinic Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Department of Urology, University Center Hamburg-Eppendorf, Hamburg, Germany |